CINACALCET TEVA 30 mg, film-coated tablet 28 tablets
Active ingredients: Cinacalcet hydrochloride, Cinacalcet
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Film-coated tablet28 tabletsorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- CINACALCET TEVA 30 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 28 plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène PVC-Aluminium de 1 comprimé(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 23 Jun 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62985754CIP73004700CIP133400930047002Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CINACALCETcomprimé | 30 mg · un comprimé | FT |
| CHLORHYDRATE DE CINACALCETcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.